Cite

HARVARD Citation

    Endo, Y. et al. (2019). Achievement of Durable and Complete Remission of Graft-versus-host Disease After Liver Transplantation With Ruxolitinib. Transplantation. 103 (11), p. . [Online]. 
  
Back to record